Key Highlights

  • 0 EPS forecasts appeared in the snapshot data for Twenty One Capital, Inc. (NYSE:XXI), which reports ahead of the opening bell on November 13, 2026, after booking 413.5 million USD of net loss for the second quarter.
  • 0.04 is the consensus EPS forecast in the snapshot data for Americas Gold and Silver Corporation (NYSEAMERICAN:USAS), which reports ahead of the opening bell on November 13, 2026, with a USD 1 billion valuation.
  • 1.01 is the projected loss per share for Helus Pharma (NASDAQ:HELP), which reports ahead of the opening bell on November 13, 2026, holding USD 166.4 million in cash as of June 30, 2026.
  • 0.08 is the consensus EPS forecast for Suncrete, Inc. (NASDAQ:RMIX), identical to the figure for Sigma Lithium, with valuations of USD 633.7 million and USD 580.85 million in the snapshot data, in that order.

Twenty One Capital, Inc. (NYSE:XXI): Bitcoin Holdings and a Heavy Quarterly Loss

Twenty One Capital, Inc. (NYSE:XXI) is slated to present third quarter 2026 results ahead of the open (BMO) on November 13, 2026. The snapshot data show no EPS forecast, and its USD 1.82 billion valuation is the biggest of the five. The second quarter brought a USD 413.5 million net loss, following USD 859.7 million during the first quarter, which lifts the loss for six months to USD 1.27 billion. Bitcoin holdings carried a USD 2.55 billion value on June 30, 2026, versus USD 3.8 billion at the end of 2025, with 16,116 bitcoin pledged against borrowings. Cash was USD 106.1 million facing USD 484.5 million in convertible notes. Raphael Zagury took over as chief executive in July 2026, and management stated that Liquidity covers operations for a minimum of twelve months. No Revenue was reported. On a calculated basis, bitcoin value slid 32.9% across six months. Hazards include bitcoin price swings, pledged collateral, approvals needed for fresh financial offerings, plus governance worries.

Americas Gold and Silver Corporation (NYSEAMERICAN:USAS): Silver Production and a Going Concern Note

Americas Gold and Silver Corporation (NYSEAMERICAN:USAS) plans to deliver third quarter 2026 results ahead of the open (BMO) on November 13, 2026. Analysts in the snapshot data forecast USD 0.04 for each share, set against a USD 1 billion valuation. The second quarter delivered a loss of USD 5.0 million, or USD 0.02 a share, meaning the forecast points to a swing back into profit. Revenue reached USD 46.3 million, a 71% gain from USD 27.0 million, and adjusted EBITDA came to USD 12.0 million. Silver output totalled 664,971 ounces, sold for close to USD 67 an ounce, while sustaining costs on an all-in basis ran USD 40.63 an ounce versus a guided range of USD 30 to USD 35. Management restated a 2026 silver output outlook between 3.2 million and 3.6 million ounces, tilted toward the back half. Cash stood at USD 88.9 million, down from USD 129.8 million. Hazards include material uncertainty about going concern, a Waiver on covenants, a June fire at Galena and swings in silver prices.

Helus Pharma (NASDAQ:HELP): Rising Outlays Before Phase 3 Data

Helus Pharma (NASDAQ:HELP), previously Cybin, presents fiscal second quarter 2027 results on November 13, 2026, ahead of the open (BMO), spanning July through September 2026. Analysts in the snapshot data forecast a loss of 1.01 for each share, and its valuation is USD 686.12 million in the snapshot data. For the preceding quarter, ended June 30, 2026, the loss was USD 47.8 million against USD 24.6 million, operating costs were USD 37.5 million against USD 23.9 million, and operations used USD 37.1 million of cash. Cash totalled USD 166.4 million, supported by an underwritten USD 50 million offering in June 2026. Enrolment in the Phase 3 APPROACH study for major depressive disorder has finished, with topline data due during the final quarter of 2026. A USD 100 million at-the-market programme could bring dilution. Revenue is nil, and no financial guidance in numbers was offered. Hazards include trial results, regulatory review and funding needs.

Suncrete, Inc. (NASDAQ:RMIX): Outlook Held After a Rainy Quarter

According to the snapshot data, Suncrete, Inc. (NASDAQ:RMIX) delivers third quarter 2026 results on November 13, 2026, ahead of the open, with a consensus EPS forecast of 0.08 and a valuation of USD 633.7 million. The forecast sits beside a USD 0.72 per-share loss for second-quarter results. Revenue climbed to USD 97.2 million from USD 39.5 million, a 146% gain, the loss was USD 37.1 million, and adjusted EBITDA reached USD 13.5 million at a 13.9% margin. Management kept its 2026 outlook of USD 420 million to USD 480 million in revenue and USD 68 million to USD 93 million in adjusted EBITDA, pointing to abnormally wet conditions. Revenue over six months was USD 159.1 million, so the outlook implies USD 260.9 million to USD 320.9 million for the back half (calculated). Cash was USD 28.6 million versus total Debt of USD 218.5 million at June 30, 2026. Hazards include weather, integrating acquisitions, squeezed margins and leverage.

Sigma Lithium (NASDAQ:SGML): Record Sales and a Mining Suspension

According to the snapshot data, Sigma Lithium (NASDAQ:SGML) delivers third quarter 2026 results on November 13, 2026, ahead of the open, with a consensus EPS forecast of 0.08 and a valuation of USD 580.85 million. Press coverage mentioned a loss near USD 0.01 on each share and revenue around USD 34.8 million, while one report cited a date of November 11, which the firm's own release should settle. Net revenue of USD 55 million during April to June was a record, alongside a 60% gross margin, a 47% EBITDA Margin and realized pricing of USD 2,089 per ton. The 2026 outlook for sustaining cash cost on an all-in basis is USD 668 per ton, while management aims for USD 620 per ton in 2027 plus a 240,000 ton run rate, delayed by three months. Mining stopped in July 2026 amid a dispute with regulators, with a restart expected after a week or two. USD 60 million had arrived under a USD 96 million offtake prepayment. Hazards include permit disputes plus lithium price swings.

Where Things Stand

Twenty One Capital, Inc. (NYSE:XXI) has no forecast and the top valuation at USD 1.82 billion. Americas Gold and Silver Corporation (NYSEAMERICAN:USAS) has a 0.04 forecast and a silver outlook of 3.2 million to 3.6 million ounces. Helus Pharma (NASDAQ:HELP) has a 1.01 projected loss and a Phase 3 readout due late in 2026. Suncrete, Inc. (NASDAQ:RMIX) has a 0.08 forecast and USD 218.5 million in debt. Sigma Lithium (NASDAQ:SGML) shares the 0.08 forecast yet carries a clashing loss figure in press coverage. All five sit ahead of the open, so Canadian investors following these names will watch each release. This article is for information only and should not be read as a recommendation.